Athena Athena

X

Digital content for AMO Pharma

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
AMO Pharma
unitedkingdom_new Flag
Country
Country
United Kingdom
Address
Address
Kemp House, 152-160 City Road, London, EC1V 2NX
Telephone
Telephone
+44 (0) 1483 319070
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.prnewswire.com/news-releases/amo-pharma-announces-collaboration-with-population-health-research-institute-to-advance-proof-of-concept-clinical-trial-to-assess-efficacy-of-tideglusib-in-treatment-of-arrhythmogenic-cardiomyopathy-302062622.html

PR NEWSWIRE
15 Feb 2024

https://www.prnewswire.com/news-releases/amo-pharma-announces-preclinical-data-showing-amo-02-improves-muscle-function-glucose-handling-and-cns-function-in-mouse-models-of-duchenne-muscular-dystrophy-301931362.html

PR NEWSWIRE
19 Sep 2023

https://www.prnewswire.com/news-releases/amo-pharma-announces-affirming-data-from-reach-cdm-clinical-trial-for-amo-02-in-treatment-of-myotonic-dystrophy-301918241.html

PR NEWSWIRE
06 Sep 2023

https://www.prnewswire.com/news-releases/amo-pharma-announces-completion-of-treatment-of-last-patient-in-pivotal-reach-cdm-clinical-trial-in-myotonic-dystrophy-301806216.html

PR NEWSWIRE
25 Apr 2023

https://www.prnewswire.com/news-releases/amo-pharma-announces-mhra-confirmation-of-cdm1-rs-as-approvable-primary-outcome-measure-in-myotonic-dystrophy-301755604.html

PR NEWSWIRE
27 Feb 2023

https://www.prnewswire.com/news-releases/amo-pharma-announces-completion-of-enrollment-in-reach-cdm-study-in-congenital-myotonic-dystrophy-301695290.html

PRNEWSWIRE
06 Dec 2022

https://www.prnewswire.com/news-releases/amo-pharma-announces-expansion-of-pivotal-reach-cdm-study-in-congenital-myotonic-dystrophy-301449576.html

PRNEWSWIRE
22 Dec 2021

https://www.prnewswire.com/news-releases/julia-jones-joins-amo-pharma-as-chief-financial-officer-and-board-member-301399675.html

PRNEWSWIRE
14 Oct 2021

https://www.prnewswire.com/news-releases/amo-pharma-announces-first-patient-enrolled-in-reach-cdm-x-12-month-open-label-study-301388304.html

PRNEWSWIRE
30 Sep 2021

https://www.prnewswire.com/news-releases/amo-pharma-announces-activation-of-additional-clinical-trial-sites-for-pivotal-reach-cdm-study-in-congenital-myotonic-dystrophy-301292105.html

PRNEWSWIRE
17 May 2021
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY